Pulmonary well-differentiated fetal adenocarcinoma with platelet-derived growth factor receptor (PDGFR)α expression

Cancer Biology and Therapy

Volumn 13, Issue 14, 2012, Pages 1384-1389

  Luo, Can Qiao ^a   Yeung, Sai Ching J ^b   Liu, Zhen Guo ^a   Meng, Jun ^a   Zhong, Fo Tian ^a   Cheng, Chao ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

catenin; Lung cancer; PDGFR ; Surgery; WDFA; Well differentiated fetal adenocarcinoma

Indexed keywords

BETA CATENIN; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; HEMOPTYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CANCER; LUNG LOBECTOMY; LUNG WELL DIFFERENTIATED FETAL ADENOCARCINOMA; LYMPH NODE DISSECTION; MALE; PROTEIN EXPRESSION;

ADENOCARCINOMA; ADULT; BETA CATENIN; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; TUMOR MARKERS, BIOLOGICAL;

EID: 84870711995     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.22253     Document Type: Article

References (28)

1. Kradin RL, Young RH, Dickersin GR, Kirkham SE, Mark EJ. Pulmonary blastoma with argyrophil cells and lacking sarcomatous features (pulmonary endodermal tumor resembling fetal lung). Am J Surg Pathol 1982; 6:165-72; PMID:6179430; http://dx.doi.org/10.1097/00000478-198203000-00009.
2. Sato S, Koike T, Yamato Y, Yoshiya K, Honma K, Tsukada H. Resected well-differentiated fetal pulmonary adenocarcinoma and summary of 25 cases reported in Japan. Jpn J Thorac Cardiovasc Surg 2006; 54:539-42; PMID:17236658; http://dx.doi.org/10.1007/s11748-006-0048-8.
3. Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, et al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011; 6:244-85; PMID:21252716; http://dx.doi.org/10.1097/JTO.0b013e318206a221.
4. Valius M, Kazlauskas A. Phospholipase C-gamma 1 and phosphatidylinositol 3 kinase are the downstream mediators of the PDGF receptor's mitogenic signal. Cell 1993; 73:321-34; PMID:7682895; http://dx.doi.org/10.1016/0092-8674(93) 90232-F.
5. Williams LT. Signal transduction by the platelet-derived growth factor receptor. Science 1989; 243:1564-70; PMID:2538922; http://dx.doi.org/10.1126/ science.2538922.
6. McDermott U, Ames RY, Iafrate AJ, Maheswaran S, Stubbs H, Greninger P, et al. Ligand-dependent platelet-derived growth factor receptor (PDGFR)-alpha activation sensitizes rare lung cancer and sarcoma cells to PDGFR kinase inhibitors. Cancer Res 2009; 69:3937-46; PMID:19366796; http://dx.doi. org/10.1158/0008-5472.CAN-08-4327.
7. Zhang P, Gao WY, Turner S, Ducatman BS. Gleevec (STI-571) inhibits lung cancer cell growth (A549) and potentiates the cisplatin effect in vitro. Mol Cancer 2003; 2:1; PMID:12537587; http://dx.doi.org/10.1186/1476-4598-2-1.
8. Zaidi A, Zamvar V, Macbeth F, Gibbs AR, Kulatilake N, Butchart EG. Pulmonary blastoma: medium-term results from a regional center. Ann Thorac Surg 2002; 73:1572-5; PMID:12022552; http://dx.doi.org/10.1016/S0003-4975(02)03494-X.
9. Nakatani Y, Kitamura H, Inayama Y, Kamijo S, Nagashima Y, Shimoyama K, et al. Pulmonary adeno-carcinomas of the fetal lung type: a clinicopathologic study indicating differences in histology, epidemiology, and natural history of low-grade and high-grade forms. Am J Surg Pathol 1998; 22:399-411; PMID:9537466; http://dx.doi.org/10.1097/00000478-199804000-00003.
10. Koss MN, Hochholzer L, O'Leary T. Pulmonary blastomas. Cancer 1991; 67:2368-81; PMID:1849449; http://dx.doi.org/10.1002/1097-0142(19910501)67: 9〈2368::AID-CNCR2820670926〉3.0.CO;2-G.
11. Zhang H, Bajraszewski N, Wu E, Wang H, Moseman AP, Dabora SL, et al. PDGFRs are critical for PI3K/Akt activation and negatively regulated by mTOR. J Clin Invest 2007; 117:730-8; PMID:17290308; http://dx.doi.org/10.1172/JCI28984.
12. Tallquist M, Kazlauskas A. PDGF signaling in cells and mice. Cytokine Growth Factor Rev 2004; 15:205-13; PMID:15207812; http://dx.doi.org/10.1016/j. cytogfr.2004.03.003.
13. Gazit A, Igarashi H, Chiu IM, Srinivasan A, Yaniv A, Tronick SR, et al. Expression of the normal human sis/PDGF-2 coding sequence induces cellular transformation. Cell 1984; 39:89-97; PMID:6091919; http://dx.doi.org/10.1016/ 0092-8674(84)90194-6.
14. Knösel T, Chen Y, Altendorf-Hofmann A, Danielczok C, Freesmeyer M, Settmacher U, et al. High KIT and PDGFRA are associated with shorter patients survival in gastroenteropancreatic neuroendocrine tumors, but mutations are a rare event. J Cancer Res Clin Oncol 2012; 138:397-403; PMID:22160160; http://dx.doi.org/10.1007/s00432-011-1107-9.
15. MacDonald TJ, Brown KM, LaFleur B, Peterson K, Lawlor C, Chen Y, et al. Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease. Nat Genet 2001; 29:143-52; PMID:11544480; http://dx.doi.org/10.1038/ng731.
16. Corless CL, Schroeder A, Griffith D, Town A, McGreevey L, Harrell P, et al. PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib. J Clin Oncol 2005; 23:5357-64; PMID:15928335; http://dx.doi.org/10.1200/JCO.2005.14.068.
17. Dagher R, Cohen M, Williams G, Rothmann M, Gobburu J, Robbie G, et al. Approval summary: imatinib mesylate in the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors. Clin Cancer Res 2002; 8:3034-8; PMID:12374669.
18. Yamazaki K. Pulmonary well-differentiated fetal adenocarcinoma expressing lineage-specific transcription factors (TTF-1 and GATA-6) to respiratory epithelial differentiation: an immunohistochemical and ultrastructural study. Virchows Arch 2003; 442:393-9; PMID:12684771.
19. Nakatani Y, Miyagi Y, Takemura T, Oka T, Yokoi T, Takagi M, et al. Aberrant nuclear/cytoplasmic localization and gene mutation of beta-catenin in classic pulmonary blastoma: beta-catenin immunostaining is useful for distinguishing between classic pulmonary blastoma and a blastomatoid variant of carcinosarcoma. Am J Surg Pathol 2004; 28:921-7; PMID:15223963; http://dx.doi.org/10.1097/00000478-200407000-00012.
20. Heldin CH, Westermark B. Platelet-derived growth factor: three isoforms and two receptor types. Trends Genet 1989; 5:108-11; PMID:2543106; http://dx.doi.org/10.1016/0168-9525(89)90040-1.
21. El Ouazzani H, Jniene A, Bouchikh M, Achachi L, El Ftouh M, Achir A, et al. Well-differentiated fetal adenocarcinoma: a very uncommon malignant lung tumor. Rev Port Pneumol 2012; 18:39-41; PMID:21778030; http://dx.doi.org/10. 1016/j.rppneu.2011.06.003.
22. Van Loo S, Boeykens E, Stappaerts I, Rutsaert R. Classic biphasic pulmonary blastoma: a case report and review of the literature. Lung Cancer 2011; 73:127-32; PMID:21513998; http://dx.doi.org/10.1016/j.lungcan.2011.03.018.
23. Fujino S, Asada Y, Konishi T, Asakura S, Kato H, Mori A. Well-differentiated fetal adenocarcinoma of lung. Lung Cancer 1995; 13:311-6; PMID:8719071; http://dx.doi.org/10.1016/0169-5002(95)00489-0.
24. Lee HJ, Goo JM, Kim KW, Im JG, Kim JH. Pulmonary blastoma: radiologic findings in five patients. Clin Imaging 2004; 28:113-8; PMID:15050223; http://dx.doi.org/10.1016/S0899-7071(03)00240-7.
25. Pilla ES, Sanchez P, Mädke GR, Camargo S, Camargo JdeJ. Pulmonary blastoma: treatment through sleeve resection of the right upper lobe. J Bras Pneumol 2006; 32:75-7; PMID:17273572; http://dx.doi.org/10.1590/S1806- 37132006000100014.
26. Longo M, Levra MG, Capelletto E, Billè A, Ardissone F, Familiari U, et al. Fetal adenocarcinoma of the lung in a 25-year-old woman. J Thorac Oncol 2008; 3:441-3; PMID:18379367; http://dx.doi.org/10.1097/JTO. 0b013e318169cd9a.
27. Wang J, Sun H, Bai R, Liu H, Yu T. Pulmonary blastoma with endobronchial growth. J Thorac Oncol 2009; 4:543-4; PMID:19333073; http://dx.doi.org/10.1097/ JTO.0b013e31819c8646.
28. Cheng C, Liu ZG, Zhang H, Xie JD, Chen XG, Zhao XQ, et al. Enhancing chemosensitivity in abcb1- and abcg2-overexpressing cells and cancer stem-like cells by an aurora kinase inhibitor cct129202. Mol Pharm 2012; PMID:22632055; http://dx.doi.org/10.1021/mp2006714.